KYKaan C. Yerit

Kaan C. Yerit

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kaan C. Yerit has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Dritan Turhani

    University Hospital of Cranio‐Maxillofacial and Oral Surgery, Medical University of Vienna, Wien, Austria

    4 shared publications
  • Franz Watzinger

    University Hospital of Cranio‐Maxillofacial and Oral Surgery, Medical University of Vienna, Wien, Austria

    4 shared publications
  • Rolf Ewers

    University Hospital of Cranio‐Maxillofacial and Oral Surgery, Medical University of Vienna, Wien, Austria

    4 shared publications
  • Arne Wagner

    University Hospital of Cranio‐Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria

    3 shared publications
  • Felix Wanschitz

    University Hospital of Cranio‐Maxillofacial and Oral Surgery, Medical University of Vienna, Vienna, Austria

    3 shared publications
  • Martin Posch

    Center for Medical Data Science Medical University of Vienna Vienna Austria

    3 shared publications

Latest Publications

  • Implant survival in mandibles of irradiated oral cancer patients

    by Kaan C. Yerit, Martin Posch, Maximilian Seemann, Sibylle Hainich, Orhun Dörtbudak, Dritan Turhani, Hakan Özyuvaci, Franz Watzinger, Rolf Ewers

    Objective: The aim of this study was to analyze long‐term implant survival in the mandible after radiotherapy and radical surgery in oral cancer patients.Study design: Between 1990 and 2003, 71 patients (15 females, 56 males; average age 57.8 years, range 16–84.1 years) were treated with dental implants after radiochemotherapy and ablative surgery of oral cancer. Radiation therapy was delivered in daily fractions of 2 Gy given on 25 days (total dose of 50 Gy). Oral defects were reconstructed microsurgically with jejunal, iliac crest or radial forearm grafts. Thereafter 316 dental implants were placed in the non‐irradiated residual bone (84; 27%), irradiated residual bone (154; 49%) or grafted bone (78; 25%) at various intervals (mean interval 1.41 (±1.01) years, range 0.34–6.35 years).Results: The mean follow‐up time after implant insertion was 5.42 (±3.21) years (range 0.3–13.61 years). The overall 2‐, 3‐, 5‐, and 8‐year survival rates of all implants were 95%, 94%, 91% and 75%. Forty‐four implants were lost in 21 patients during the observation period. Irradiation of the mandibular bone showed significantly (P=0.0028) lower implant survival compared with non‐irradiated mandibular bone. The 8‐year survival rate in the non‐irradiated residual bone (two loss), irradiated residual bone (29 loss) or grafted bone (13 loss) were 95%, 72% and 54%, respectively. Time of implantation after irradiation showed no statistically significant influence. Implant brand, length or diameter or the incidence of resective surgery on the mandible and gender of patients had no statistically significant influence on implant survival.Conclusion: Radiation therapy with 50 Gy was significantly related to shorter implant survival in mandibular bone. Survival was lowest in grafted bone. Time of implant placement had no statistically significant influence on survival under the conditions of this study. Although implant survival is lower in irradiated mandibles, implants significantly facilitate prosthodontic treatment and enhance outcome of oral rehabilitation in cancer patients.


  • Long‐term implant survival in the grafted maxilla: results of a 12‐year retrospective study

    by Kaan C. Yerit, Martin Posch, Sibylle Hainich, Dritan Turhani, Clemens Klug, Felix Wanschitz, Arne Wagner, Franz Watzinger, Rolf Ewers

    Objective: The aim of this study was to determine the long‐term outcome of implant insertion in the augmented severely atrophied maxilla.Study design: Three hundred and twenty‐four implants were inserted in 35 patients (eight males, 27 females, average age 57.6 years) in extremely atrophied maxillae after osteotomy and interposition of iliac crest bone. One hundred implants were installed in 12 patients simultaneously with the osteotomy and grafting; 224 implants were placed in 23 patients in a second procedure 6–12 months later. Implant parameters like osseointegration and peri‐implant bone loss; peri‐implant tissue parameters like bleeding, gingival and plaque index; and patients' satisfaction were evaluated.Results: Of 324 implants, 29 (8.9%) were lost during the entire follow‐up: 14 in six patients of the one‐step and 15 in 11 patients of the two‐step group. The overall input–output survival in 141.1 months was 91.1%. The overall 2‐year failure‐free fraction of implants was 95.5%; the 5‐year failure‐free fraction was 89.3%. In the one‐step group, the 2 (5)‐year failure‐free fraction was 95.9% (86.9%), and in the two‐step group 95% (91.3%) (log‐rank test P=0.57). Marginal peri‐implant bone loss was 1.7±1.3 mm mesial and 1.8±1.3 mm distal.Conclusion: Implant insertion after osteotomy and iliac bone grafting is a reliable operation method for the dental rehabilitation of the severely atrophied maxilla showing good long‐term results.


  • Rehabilitation of the severely atrophied maxilla by horseshoe Le Fort I osteotomy (HLFO)

    by Kaan C. Yerit, Martin Posch, Ulrich Guserl, Dritan Turhani, Christian Schopper, Felix Wanschitz, Arne Wagner, Franz Watzinger, Rolf Ewers


  • Fixation of mandibular fractures with biodegradable plates and screws

    by Kaan C. Yerit, Georg Enislidis, Christian Schopper, Dritan Turhani, Felix Wanschitz, Arne Wagner, Franz Watzinger, Rolf Ewers